Surveillance of adverse events following immunisation in Australia annual report, 2021

Authors

  • Yuanfei Anny Huang National Centre for Immunisation Research and Surveillance, Locked Bag 4001, Westmead NSW 2145, Sydney, Australia
  • Catherine Glover National Centre for Immunisation Research and Surveillance, The University of Sydney and The Children’s Hospital at Westmead, Sydney
  • Lucy Deng National Centre for Immunisation Research and Surveillance, The University of Sydney and The Children’s Hospital at Westmead, Sydney
  • Kristine Macartney National Centre for Immunisation Research and Surveillance, The University of Sydney and The Children’s Hospital at Westmead, Sydney
  • Nicholas Wood National Centre for Immunisation Research and Surveillance, The University of Sydney and The Children’s Hospital at Westmead, Sydney
  • Claire Larter Pharmacovigilance Branch, Therapeutic Goods Administration, Department of Health and Aged Care, Canberra, Australia
  • Catherine Brogan Pharmacovigilance Branch, Therapeutic Goods Administration, Department of Health and Aged Care, Canberra, Australia
  • Olivia Richardson Pharmacovigilance Branch, Therapeutic Goods Administration, Department of Health and Aged Care, Canberra, Australia
  • Elspeth Kay Pharmacovigilance Branch, Therapeutic Goods Administration, Department of Health and Aged Care, Canberra, Australia

DOI:

https://doi.org/10.33321/cdi.2024.48.1

Keywords:

AEFI, adverse effects, vaccines, surveillance, immunisation, vaccine

Abstract

This report summarises Australia’s spontaneous surveillance data for adverse events following immunisation (AEFI) for 2021 reported to the Therapeutic Goods Administration (TGA) and describes reporting trends over the 22-year period 1 January 2000 to 31 December 2021. This report excludes AEFI reports featuring pandemic coronavirus disease 2019 (COVID-19) vaccines, which are reported separately.

There were 3,452 AEFI reports for non-COVID-19 vaccines administered in 2021, an annual AEFI reporting rate of 13.4 per 100,000 population compared with 14.9 per 100,000 population in 2020. This small decrease in the AEFI reporting rate in 2021 could potentially be related to an increased focus on COVID-19 vaccines and related AEFI, which are not included in this report. AEFI reporting rates for individual vaccines in 2021 were similar to 2020, as were the most commonly reported adverse events. Of the six deaths following vaccination in 2021 reported to the TGA, none were found to have a causal relationship with vaccination.

Downloads

Download data is not yet available.

References

Council for International Organizations of Medical Sciences (CIOMS) c/o World Health Organization (WHO). Definition and Application of Terms for Vaccine Pharmacovigilance: Report of CIOMS/WHO Working Group on Vaccine Pharmacovigilance. Geneva: CIOMS; 2012. Available from: https://www.who.int/vaccine_safety/initiative/tools/CIOMS_report_WG_vaccine.pdf.

Australian Technical Advisory Group on Immunisation (ATAGI). Australian Immunisation Handbook. Canberra: Australian Government Department of Health and Aged Care; 2020. Available from: https://immunisationhandbook.health.gov.au/.

Uppsala Monitoring Centre. WHO Collaborating Centre for International Drug Monitoring. [Website.] Uppsala: Uppsala Monitoring Centre; 2020. Available from: http://www.who-umc.org/.

Uppsala Monitoring Centre. The use of the WHO-UMC system for standardised case causality assessment. Uppsala: Uppsala Monitoring Centre; 6 April 2018. Available from: https://who-umc.org/media/164200/who-umc-causality-assessment_new-logo.pdf.

Dey A, Wang H, Quinn H, Hill R, Macartney K. Surveillance of adverse events following immunisation in Australia annual report, 2014. Commun Dis Intell Q Rep. 2016;40(3):E377–90.

Lawrence G, Boyd I, McIntyre P, Isaacs D. Surveillance of adverse events following immunisation: Australia 2002 to 2003. Commun Dis Intell Q Rep. 2004;28(3):324–38.

Lawrence G, Boyd I, McIntyre P, Isaacs D. Annual report: surveillance of adverse events following immunisation in Australia, 2005. Commun Dis Intell Q Rep. 2006;30(3):319–33.

Lawrence G, Gold MS, Hill R, Deeks S, Glasswell A, McIntyre PB. Annual report: surveillance of adverse events following immunisation in Australia, 2007. Commun Dis Intell Q Rep. 2008;32(4):371–87.

Lawrence G, Menzies R, Burgess M, McIntyre P, Wood N, Boyd I et al. Surveillance of adverse events following immunisation: Australia, 2000–2002. Commun Dis Intell Q Rep. 2003;27(3):307–23.

Lawrence GL, Aratchige PE, Boyd I, McIntyre PB, Gold MS. Annual report on surveillance of adverse events following immunisation in Australia, 2006. Commun Dis Intell Q Rep. 2007;31(3):269–82.

Lawrence GL, Boyd I, McIntyre PB, Isaacs D. Annual report: surveillance of adverse events following immunisation in Australia, 2004. Commun Dis Intell Q Rep. 2005;29(3):248–62.

Mahajan D, Cook J, Dey A, Macartney K, Menzies R. Supplementary report: surveillance of adverse events following immunisation among children aged less than seven years in Australia, 1 January to 30 June 2012. Commun Dis Intell Q Rep. 2013;37(2):E130–4.

Mahajan D, Cook J, Dey A, Macartney K, Menzies RI. Annual report: surveillance of adverse events following immunisation in Australia, 2011. Commun Dis Intell Q Rep. 2012;36(4):E315–32.

Mahajan D, Cook J, McIntyre P, Macartney K, Menzies R. Supplementary report: surveillance of adverse events following immunisation among children aged less than seven years in Australia, 1 January to 30 June 2011. Commun Dis Intell Q Rep. 2012;36(1):114–9.

Mahajan D, Cook J, McIntyre PB, Macartney K, Menzies RI. Annual report: surveillance of adverse events following immunisation in Australia, 2010. Commun Dis Intell Q Rep. 2011;35(4):263–80.

Mahajan D, Roomiani I, Gold MS, Lawrence GL, McIntyre PB, Menzies RI. Annual report: surveillance of adverse events following immunisation in Australia, 2009. Commun Dis Intell Q Rep. 2010;34(3):259–76.

Menzies R, Mahajan D, Gold MS, Roomiani I, McIntyre P, Lawrence G. Annual report: surveillance of adverse events following immunisation in Australia, 2008. Commun Dis Intell Q Rep. 2009;33(4):365–81.

Mahajan D, Dey A, Cook J, Harvey B, Menzies R, Macartney K. Surveillance of adverse events following immunisation in Australia annual report, 2013. Commun Dis Intell Q Rep. 2015;39(3):E369–86.

Dey A, Wang H, Quinn H, Pillsbury A, Glover C, Hickie M et al. Surveillance of adverse events following immunisation in Australia annual report, 2019. Commun Dis Intell (2018). 2021;45. doi: https://doi.org/10.33321/cdi.2021.45.23.

Dey A, Wang H, Quinn H, Pillsbury A, Hickie M, Deng L et al. Surveillance of adverse events following immunisation in Australia annual report, 2020. Commun Dis Intell (2018). 2022;46. doi: https://doi.org/10.33321/cdi.2022.46.47.

Glover C, Deng L, Larter C, Brogan C, Richardson O, Huang YA et al. Surveillance of adverse events following immunisation in Australia, COVID-19 vaccines, 2021. Commun Dis Intell (2018). 2024;48. doi: https://doi.org/10.33321/cdi.2024.48.2.

Brown EG. Using MedDRA: implications for risk management. Drug Saf. 2004;27(8):591–602. doi: https://doi.org/10.2165/00002018-200427080-00010.

Brown EG, Wood L, Wood S. The medical dictionary for regulatory activities (MedDRA). Drug Saf. 1999;20(2):109–17. doi: https://doi.org/10.2165/00002018-199920020-00002.

Medical Dictionary for Regulatory Activities (MedDRA). Standardised MedDRA Queries. [Webpage.] Herndon VA: MedDRA: 2023. Available from: https://www.meddra.org/standardised-meddra-queries.

WHO. Causality assessment of an adverse event following immunization (AEFI): user manual for the revised WHO classification, 2nd ed., 2019 update. Geneva: WHO; 16 April 2021. Available from: https://www.who.int/publications/i/item/9789241516990.

Zhou W, Pool V, Iskander JK, English-Bullard R, Ball R, Wise RP et al. Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)—United States, 1991–2001. MMWR Surveill Summ. 2003;52(1):1–24.

Australian Bureau of Statistics. National, state and territory population. Reference period: June 2021. [Webpage.] Canberra: Australian Bureau of Standards; 16 December 2021. Available from: https://www.abs.gov.au/statistics/people/population/national-state-and-territory-population/jun-2021.

Australian Government: Services Australia. Australian Immunisation Register. [Webpage.] Canberra: Services Australia. Available from: https://www.servicesaustralia.gov.au/australian-immunisation-register.

Australian Government Department of Health and Aged Care, TGA. Database of Adverse Event Notifications. [Internet.] Canberra: Australian Government Department of Health and Aged Care. [Accessed on 26 March 2013.] Available from: http://www.tga.gov.au/safety/daen.htm.

Hull B, Hendry A, Dey A, Brotheron J, Macartney K, Beard F. Annual Immunisation Coverage Report 2021. Commun Dis Intell (2018). 2023;47. doi: https://doi.org/10.33321/cdi.2023.47.47.

Hull BP, Hendry AJ, Dey A, Bryant K, Radkowski C, Pellissier S et al. The impact of the COVID-19 pandemic on routine vaccinations in Victoria. Med J Aust. 2021;215(2):83–4. doi: https://doi.org/10.5694/mja2.51145.

Dey A, Wang H, Quinn H, Pillsbury A, Glover C, Hickie M et al. Surveillance of adverse events following immunisation in Australia annual report, 2018. Commun Dis Intell (2018). 2020;44. doi: https://doi.org/10.33321/cdi.2020.44.12.

Australian Government Department of Health and Aged Care. Vaccine safety in Australia: AusVaxSafety summary report 2021. Canberra: Australian Government Department of Health and Aged Care; 29 September 2022. Available from: https://www.health.gov.au/resources/publications/vaccine-safety-in-australia-ausvaxsafety-summary-report-2021.

Varricchio F, Iskander J, Destefano F, Ball R, Pless R, Braun MM et al. Understanding vaccine safety information from the Vaccine Adverse Event Reporting System. Pediatr Infect Dis J. 2004;23(4):287–94. doi: https://doi.org/10.1097/00006454-200404000-00002.

Mahajan D, Reid S, Cook J, Macartney K, Menzies R. NSW annual report describing adverse events following immunisation, 2011. NSW Public Health Bull. 2012;23(9–10):187–200. doi: https://doi.org/10.1071/NB12081.

Downloads

Published

26/04/24

How to Cite

Huang, Yuanfei Anny, Catherine Glover, Lucy Deng, Kristine Macartney, Nicholas Wood, Claire Larter, Catherine Brogan, Olivia Richardson, and Elspeth Kay. 2024. “Surveillance of Adverse Events Following Immunisation in Australia Annual Report, 2021”. Communicable Diseases Intelligence 48 (April). https://doi.org/10.33321/cdi.2024.48.1.

Issue

Vol. 48 (2024)

Section

Annual report

Categories

License

Copyright (c) 2024 Communicable Diseases Intelligence

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Most read articles by the same author(s)

1 2 3 4 5 6 > >>